BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17233196)

  • 1. Lipid lowering inefficacy of high-dose statin therapy due to concurrent use of phenytoin.
    Khandwala HM
    South Med J; 2006 Dec; 99(12):1385-7. PubMed ID: 17233196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins and phenytoin interact - a case history.
    Tan KM; Kelly JG; McGarry K
    Br J Clin Pharmacol; 2008 Jan; 65(1):147-8. PubMed ID: 17610524
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lowering cholesterol 1998. Cholesterol synthesis inhibitors compared].
    Kostner KM; Kostner GM
    Wien Klin Wochenschr; 1998 Oct; 110(18):625-30. PubMed ID: 9816634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.
    Williams D; Feely J
    Clin Pharmacokinet; 2002; 41(5):343-70. PubMed ID: 12036392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-drug interactions that interfere with statin metabolism.
    Hirota T; Ieiri I
    Expert Opin Drug Metab Toxicol; 2015; 11(9):1435-47. PubMed ID: 26058399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of statin therapy: possible effect of phenytoin.
    Murphy MJ; Dominiczak MH
    Postgrad Med J; 1999 Jun; 75(884):359-60. PubMed ID: 10435174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of a statine of the most recent generation].
    Notarbartolo A; Barbagallo CM
    Ital Heart J Suppl; 2001 Mar; 2(3):230-4. PubMed ID: 11307781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical equivalence of proprietary and generic atorvastatin in lipid clinic patients.
    Rahalkar AR; Ban MR; Hegele RA
    Can J Cardiol; 2013 Apr; 29(4):418-22. PubMed ID: 22840301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type of preexisting lipid therapy predicts LDL-C response to ezetimibe.
    Meyers CD; Moon YS; Ghanem H; Wong ND
    Ann Pharmacother; 2006 May; 40(5):818-23. PubMed ID: 16638916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achieving target cholesterol levels in diabetic patients: potency of the statin or potency of the physician?
    Shani M; Dresner J; Vinker S
    Isr Med Assoc J; 2008 May; 10(5):354-7. PubMed ID: 18605358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of thyroid hormone status and concomitant medication on statin induced adverse effects in hyperlipidemic patients.
    Berta E; Harangi M; Zsíros N; Nagy EV; Paragh G; Bodor M
    Pharmazie; 2014 Jun; 69(6):420-3. PubMed ID: 24974574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
    Baldassarre S; Scruel O; Deckelbaum RJ; Dupont IE; Ducobu J; Carpentier YA
    Int J Cardiol; 2005 Oct; 104(3):338-45. PubMed ID: 16186066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety of aggressive statin therapy: how much can low-density lipoprotein cholesterol be lowered?
    Jacobson TA
    Mayo Clin Proc; 2006 Sep; 81(9):1225-31. PubMed ID: 16970219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are all statins the same? Focus on the efficacy and tolerability of pitavastatin.
    da Silva PM
    Am J Cardiovasc Drugs; 2011; 11(2):93-107. PubMed ID: 21446776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
    Pedersen TR
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics and pharmacogenomics of cholesterol-lowering therapy.
    Schmitz G; Schmitz-Madry A; Ugocsai P
    Curr Opin Lipidol; 2007 Apr; 18(2):164-73. PubMed ID: 17353665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lamotrigine and phenytoin on the pharmacokinetics of atorvastatin in healthy volunteers.
    Bullman J; Nicholls A; Van Landingham K; Fleck R; Vuong A; Miller J; Alexander S; Messenheimer J
    Epilepsia; 2011 Jul; 52(7):1351-8. PubMed ID: 21635243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grapefruit Juice and Statins.
    Lee JW; Morris JK; Wald NJ
    Am J Med; 2016 Jan; 129(1):26-9. PubMed ID: 26299317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.